Skip to content

The AMD Experts

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to turn their practice into an AMD Center of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Our Blog: May 3, 2021

The Secret to Successful AMD Programs: 4 Steps for Standardization

Getting to know your practice and what drives you to take great care of your patients, especially when it comes to AMD, is crucial. Christine Akers, Practice Management Consultant at MacuLogix, gives 4 steps for standardization for a successful AMD Program.

Article: April 15, 2021 | Review of Optometry

New Options, Front to Back

It’s an exciting time to be in eye care with so many new tools available and in the development pipeline. The AdaptDx Pro is a dark adaptomter that measures dark adaptation speed. This can be used to identify AMD with 90% sensitivity.

Article: April 3, 2021 | Review of Optometry

New Language Options Enhance AMD Screenings

Your technician can operate the AdaptDx Pro in one language while selecting a different one for the patient to experience. Tailoring patient instructions to their native language can improve communication and trust.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.